Class of warrant or right exercisable number.

No definition available.

Name:	srne_ClassOfWarrantOrRightExercisableNumber
Namespace Prefix:	srne_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Class of warrant or right, period in which warrants can be exercised from grant date

+ References

No definition available.

+ Details

Name:	srne_ClassOfWarrantOrRightPeriodInWhichWarrantsCanBeExercisedFromGrantDate
Namespace Prefix:	srne_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Share based compensation employee option grants vesting rate.

+ References

No definition available.

+ Details

Name:	srne_ShareBasedCompensationEmployeeOptionGrantsVestingRate
Namespace Prefix:	srne_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14.F)
-URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)(i)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name:	us-gaap_AllocatedShareBasedCompensationExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Exercise price per share or per unit of warrants or rights outstanding.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(i)(4))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name:	us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix:	us-gaap_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.

+ References

No definition available.

+ Details

Name:	us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Aggregate number of common shares reserved for future issuance.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name:	us-gaap_CommonStockCapitalSharesReservedForFutureIssuance
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

The maximum number of common shares permitted to be issued by an entity's charter and bylaws.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name:	us-gaap_CommonStockSharesAuthorized
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

+ Details

Name:	us-gaap_CommonStockVotingRights
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Unrecognized cost of unvested share-based compensation awards.

+ References

+ Details

Name:	us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

+ Details

Name:	us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Unrecognized cost of unvested options awarded to employees as compensation.

+ References

No definition available.

+ Details

Name:	us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Description of award terms as to how many shares or portion of an award are no longer contingent on satisfaction of either a service condition, market condition or a performance condition, thereby giving the employee the legal right to convert the award to shares, to sell the shares, and be entitled to the cash proceeds of such sale. For example, vesting may be expressed as being 25 percent of the shares under option on each anniversary of the grant date.

+ References

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.

+ References

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.

+ References

No definition available.

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.

+ References

No definition available.

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

For each plan, identification of the award pricing model or other valuation method used in calculating the weighted average fair values disclosed. The model is also used to calculate the compensation expense that is shown within the balance sheet, income statement, and cash flow. Examples of valuation techniques are lattice models (binomial model), closed-form models (Black-Scholes-Merton formula), and a Monte Carlo simulation technique. Fair value is the amount at which an asset or liability could be bought or incurred or sold or settled in a current transaction between willing parties, that is, other than in a forced or liquidation sale. May include disclosures about the assumptions underlying application of the method selected.

+ References

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsMethodUsed
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.

+ References

No definition available.

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.

+ References

No definition available.

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).

+ References

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.

+ References

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.

+ References

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Gross number of share options (or share units) granted during the period.

+ References

No definition available.

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of options outstanding, including both vested and non-vested options.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)-(ii)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.

+ References

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
Namespace Prefix:	us-gaap_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

+ Details

Name:	us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(i)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14.D.2)
-URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809

+ Details

Name:	us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

+ Details

Name:	us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_PlanNameAxis=srne_TwoThousandNineNonEmployeeDirectorGrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TitleOfIndividualAxis=srne_NonEmployeeDirectorsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RangeAxis=us-gaap_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_PlanNameAxis=srne_TwoThousandNineStockIncentivePlanMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TitleOfIndividualAxis=srne_EmployeeAndDirectorMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TitleOfIndividualAxis=srne_NonEmployeeConsultantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_PlanNameAxis=srne_TwoThousandFifteenStockOptionPlanMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=srne_TNKTherapeuticsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=srne_LACellMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=srne_ConcortisBiosystemsCorporationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=srne_ScintillaPharmaceuticalsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=srne_SorrentoBiologicsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RangeAxis=us-gaap_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TitleOfIndividualAxis=us-gaap_ChiefExecutiveOfficerMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TitleOfIndividualAxis=us-gaap_DirectorMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TitleOfIndividualAxis=srne_DirectorsAndNonEmployeeConsultantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_PlanNameAxis=srne_TwoThousandFourteenEmployeeStockOptionPlanMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TitleOfIndividualAxis=srne_DirectorsAndConsultantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=srne_ArkAnimalHealthIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Stockholders' Equity - Additional Information (Detail) - USD ($)	1 Months Ended				12 Months Ended
	Nov. 30, 2015	Oct. 31, 2015	May 31, 2015	May 31, 2014	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Oct. 13, 2015	Dec. 31, 2013	Sep. 30, 2009
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Common stock, shares authorized					750,000,000	750,000,000
Common stock reserved for issuance					7,740,340
2009 Non-Employee Director Grants [Member] \| Non Employee Directors
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Common stock reserved for issuance										8,000
Outstanding options vesting anniversary period					1 year
Shares available for grant					0
Option outstanding					3,200
Weighted-average exercise price					$ 1.12
2009 Non-Employee Director Grants [Member] \| Non Employee Directors \| Maximum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Outstanding options exercisable period					10 years
2009 Stock Incentive Plan [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Outstanding options exercisable period					10 years
Option outstanding					4,332,876	2,957,616	2,231,800		1,044,100
Weighted-average exercise price					$ 7.86	$ 8.95	$ 6.34		$ 6.52
Common stock, shares authorized					6,260,000
Employee option grants vested					25.00%
Aggregate intrinsic value of options exercised					$ 194,000	$ 2,411,000	$ 230,000
Unrecognized compensation cost related to unvested stock option grants					$ 10,192,000
Period for recognized compensation cost					2 years 7 months 6 days
Options Granted, Options Outstanding					2,034,050	1,378,600	1,577,000
2009 Stock Incentive Plan [Member] \| Employee and Director [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation					$ 4,354,000	$ 5,198,000	$ 2,796,000
2009 Stock Incentive Plan [Member] \| Non-Employee consultants [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation					$ 387,000	1,481,000	$ 678,000
2015 Stock Incentive Plan [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Option outstanding					1,400,000
Stock options vesting rights under 2009 stock incentive plan					Stock options granted under this plan typically vest a portion immediately upon grant and the remaining options over two to four years or monthly over four years from the grant date and have a contractual term of ten years.
Options Granted, Options Outstanding		2,600,000
Stock options, contractual term		10 years
2015 Stock Incentive Plan [Member] \| Common Class A
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Common stock reserved for issuance		10,000,000
2015 Stock Incentive Plan [Member] \| T N K Therapeutics Inc
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Option outstanding					3,000,000
Stock options vesting rights under 2009 stock incentive plan					Stock options granted under this plan typically vest a portion immediately upon grant and the remaining options over two to four years or monthly over four years from the grant date and have a contractual term of ten years.
Options Granted, Options Outstanding	500,000		3,600,000
Stock options, contractual term					10 years
Warrant shares exercisable			4,000,000
Warrant exercise price per share			$ 0.01
2015 Stock Incentive Plan [Member] \| T N K Therapeutics Inc \| Common Class A
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Common stock reserved for issuance			10,000,000
2015 Stock Incentive Plan [Member] \| LA Cell [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Option outstanding					2,100,000
Stock options vesting rights under 2009 stock incentive plan					Stock options granted under this plan typically vest a portion immediately upon grant and the remaining options over two to four years or monthly over four years from the grant date and have a contractual term of ten years.
Options Granted, Options Outstanding			2,900,000
Stock options, contractual term			10 years
Warrant shares exercisable			4,000,000
Warrant exercise price per share			$ 0.01
2015 Stock Incentive Plan [Member] \| LA Cell [Member] \| Common Class A
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Common stock reserved for issuance			10,000,000
2015 Stock Incentive Plan [Member] \| Concortis Biosystems, Corp. [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Option outstanding					1,800,000
Stock options vesting rights under 2009 stock incentive plan					Stock options granted under this plan typically vest a portion immediately upon grant and the remaining options over two to four years or monthly over four years from the grant date and have a contractual term of ten years.
Options Granted, Options Outstanding		1,800,000
Stock options, contractual term		10 years
Warrant shares exercisable		4,000,000
Warrant exercise price per share		$ 0.25
2015 Stock Incentive Plan [Member] \| Concortis Biosystems, Corp. [Member] \| Common Class A
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Common stock reserved for issuance		10,000,000
2015 Stock Incentive Plan [Member] \| Scintilla Pharmaceuticals, Inc [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Option outstanding					1,000,000
Stock options vesting rights under 2009 stock incentive plan					Stock options granted under this plan typically vest a portion immediately upon grant and the remaining options over two to four years or monthly over four years from the grant date and have a contractual term of ten years.
Stock options, contractual term		10 years
Warrant shares exercisable		4,000,000
Warrant exercise price per share		$ 0.01
2015 Stock Incentive Plan [Member] \| Scintilla Pharmaceuticals, Inc [Member] \| Common Class A
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Common stock reserved for issuance								10,000,000
Options Granted, Options Outstanding		2,100,000
2015 Stock Incentive Plan [Member] \| Sorrento Biologics, Inc [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Warrant shares exercisable		4,000,000
Warrant exercise price per share		$ 0.01
2015 Stock Incentive Plan [Member] \| Maximum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Outstanding options vesting anniversary period		4 years
2015 Stock Incentive Plan [Member] \| Maximum [Member] \| T N K Therapeutics Inc
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Outstanding options vesting anniversary period					4 years
Warrant exercisable period			4 years
2015 Stock Incentive Plan [Member] \| Maximum [Member] \| LA Cell [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Outstanding options vesting anniversary period			4 years
Warrant exercisable period			4 years
2015 Stock Incentive Plan [Member] \| Maximum [Member] \| Concortis Biosystems, Corp. [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Outstanding options vesting anniversary period		4 years
Warrant exercisable period		4 years
2015 Stock Incentive Plan [Member] \| Maximum [Member] \| Scintilla Pharmaceuticals, Inc [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Outstanding options vesting anniversary period		4 years
Warrant exercisable period		4 years
2015 Stock Incentive Plan [Member] \| Maximum [Member] \| Sorrento Biologics, Inc [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Warrant exercisable period		4 years
2015 Stock Incentive Plan [Member] \| Minimum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Outstanding options vesting anniversary period		2 years
2015 Stock Incentive Plan [Member] \| Minimum [Member] \| T N K Therapeutics Inc
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Outstanding options vesting anniversary period					2 years
Warrant exercisable period			40 months
2015 Stock Incentive Plan [Member] \| Minimum [Member] \| LA Cell [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Outstanding options vesting anniversary period			2 years
Warrant exercisable period			40 months
2015 Stock Incentive Plan [Member] \| Minimum [Member] \| Concortis Biosystems, Corp. [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Outstanding options vesting anniversary period		2 years
Warrant exercisable period		40 months
2015 Stock Incentive Plan [Member] \| Minimum [Member] \| Scintilla Pharmaceuticals, Inc [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Outstanding options vesting anniversary period		2 years
Warrant exercisable period		40 months
2015 Stock Incentive Plan [Member] \| Minimum [Member] \| Sorrento Biologics, Inc [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Warrant exercisable period		40 months
2015 Stock Incentive Plan [Member] \| Non-Employee consultants [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation					$ 189,000	97,000
2015 Stock Incentive Plan [Member] \| CEO [Member] \| T N K Therapeutics Inc \| Class B [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Warrant granted to purchase common stock			9,500,000
Voting rights					10 to 1
2015 Stock Incentive Plan [Member] \| CEO [Member] \| LA Cell [Member] \| Class B [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Warrant granted to purchase common stock			9,500,000
Voting rights					10 to 1
2015 Stock Incentive Plan [Member] \| CEO [Member] \| Concortis Biosystems, Corp. [Member] \| Class B [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Warrant granted to purchase common stock		9,500,000
Voting rights					10 to 1
2015 Stock Incentive Plan [Member] \| CEO [Member] \| Scintilla Pharmaceuticals, Inc [Member] \| Class B [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Warrant granted to purchase common stock		9,500,000
Voting rights					10 to 1
2015 Stock Incentive Plan [Member] \| CEO [Member] \| Sorrento Biologics, Inc [Member] \| Class B [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Warrant granted to purchase common stock		9,500,000
Voting rights					10 to 1
2015 Stock Incentive Plan [Member] \| Director [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation					$ 166,000	140,000
Period for recognized compensation cost					3 years 6 months
Unrecognized compensation cost related to unvested stock option and warrant grants					$ 367,000
2015 Stock Incentive Plan [Member] \| Directors and Non-Employee Consultants [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Method used to determine the fair value of stock option and warrant					Black-Scholes option and warrant pricing model
Dividend yield					0.00%
Risk-free interest rate, minimum					1.39%
Risk-free interest rate, maximum					2.24%
Expected volatility, minimum					76.00%
Expected volatility, maximum					77.00%
2015 Stock Incentive Plan [Member] \| Directors and Non-Employee Consultants [Member] \| Maximum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected life of options					6 years 1 month 6 days
2015 Stock Incentive Plan [Member] \| Directors and Non-Employee Consultants [Member] \| Minimum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected life of options					4 years
2014 Stock Option Plan [Member] \| Directors and Consultants [Member] \| Ark Animal Health, Inc. [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation					$ 0	$ 56,000
Outstanding options vesting anniversary period				1 year
Option outstanding					322,000
Unrecognized compensation cost related to unvested stock option grants					$ 0
Options Granted, Options Outstanding				600,000
Stock options, contractual term				10 years
Method used to determine the fair value of stock option and warrant					Black-Scholes option pricing model
Dividend yield						0.00%	0.00%
Risk-free interest rate, minimum						1.94%	1.94%
Risk-free interest rate, maximum						2.27%	2.60%
Expected volatility, minimum						75.00%	75.00%
Expected volatility, maximum						78.00%	78.00%
2014 Stock Option Plan [Member] \| Directors and Consultants [Member] \| Maximum [Member] \| Ark Animal Health, Inc. [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected life of options						10 years	10 years
2014 Stock Option Plan [Member] \| Directors and Consultants [Member] \| Minimum [Member] \| Ark Animal Health, Inc. [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected life of options						6 years 29 days	6 years 29 days
Restricted Equity [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation					$ 4,700,000	$ 7,000,000	$ 3,900,000
Outstanding options [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Dividend yield					0.00%	0.00%	0.00%
Expected life of options					6 years 1 month 6 days	6 years 1 month 6 days	6 years 1 month 6 days
Outstanding options [Member] \| 2009 Stock Incentive Plan [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Outstanding options vesting anniversary period					3 years
Stock options vesting rights under 2009 stock incentive plan					Employee option grants generally vest 25% on the first anniversary of the original vesting commencement date, with the balance vesting monthly over the remaining three years.